‘Jawbone Death’ and the Law: The Latest Fosamax Trial Rolls On

By: Seeger Weiss on November 12, 2010

The condition, a debilitating jaw deterioration, has taken center stage in a trial in Manhattan over Merck’s drug Fosamax, which thousands have alleged causes the condition.

From the Wall Street Journal Law Blog:

The condition, a debilitating jaw deterioration, has taken center stage in a trial in Manhattan over Merck’s drug Fosamax, which thousands have alleged causes the condition. Fosamax is most typically prescribed to older women with thinning bones.

The case is pitting Judith Graves, a 67-year-old retired investigator for the United States Army, against Merck. According to the NYT, her lawyer, Timothy O’Brien recently told the jury that Graves’s jaw deterioration, allegedly caused by Fosamax, had required five surgeries, including one to replace part of her jaw with a bone from her left arm.

Free Case Evaluation Fill out the form for a Free Case Evaluation within 24 hours

By submitting this form I agree to the terms of SeegerWeiss.com Disclaimer and Privacy Policy

Handling Cases Nationwide

we support

Sign Up to our Consumer Alerts Newletter
Free Case Evaluation Fill out the form for a Free Case Evaluation within 24 hours

By submitting this form I agree to the terms of SeegerWeiss.com Disclaimer and Privacy Policy

×